Nippon India Pharma Fund - Direct (G) vs SBI Arbitrage Opportunities Fund - Direct (G)

Nippon India Pharma Fund - Direct (G) vs SBI Arbitrage Opportunities Fund - Direct (G)

stock1

Nippon India Pharma Fund - Direct (G)

7.4%

stock2

SBI Arbitrage Opportunities Fund - Direct (G)

6.39%

Loading chart...

About Fund

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Citi Bank HDFC Bank Ltd. Stock Holding Corporation of India

Computer Age Management Services Pvt. Ltd Computronics Financial Services India Ltd Datamatics Financial Software Services Ltd

Very High Risk

5000

9044.23

1.12

634.5023

January 1, 2013

1

Low Risk

5000

45923.07

0.73

38.4577

January 1, 2013

0

14.01 %

19.35 %

7.4 %

6.74 %

7.43 %

6.39 %

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Neeraj Kumar

CA

He has over 14 years of experience in India Financial Services and Capital Markets in various capacities. He has rich experience in Equity Trading and Equity Research. Prior to Joining SBI Funds Management he was working with Life Insurance corporation of India.

Get your FAQs right